Literature DB >> 12163366

Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses.

José Ignacio Martín-Subero1, Ilse Chudoba, Lana Harder, Stefan Gesk, Werner Grote, Francisco Javier Novo, María José Calasanz, Reiner Siebert.   

Abstract

Phenotypic and genotypic analyses of cells are increasingly essential for understanding pathogenetic mechanisms as well as for diagnosing and classifying malignancies and other diseases. We report a novel multicolor approach based on the FICTION (fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of neoplasms) technique, which enables the simultaneous detection of morphological, immunophenotypic, and genetic characteristics of single cells. As prerequisite, multicolor interphase fluorescence in situ hybridization assays for B-cell non-Hodgkin's lymphoma and anaplastic large-cell lymphoma have been developed. These assays allow the simultaneous detection of the most frequent primary chromosomal aberrations in these neoplasms, such as t(8;14), t(11;14), t(14;18), and t(3;14), and the various rearrangements of the ALK gene, respectively. To establish the multicolor FICTION technique, these assays were combined with the immunophenotypic detection of lineage- or tumor-specific antigens, namely CD20 and ALK, respectively. For evaluation of multicolor FICTION experiments, image acquisition was performed by automatic sequential capturing of multiple focal planes. Thus, three-dimensional information was obtained. The multicolor FICTION assays were applied to well-characterized lymphoma samples, proving the performance, validity, and diagnostic power of the technique. Future multicolor FICTION applications include the detection of preneoplastic lesions, early stage and minimal residual diseases, or micrometastases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163366      PMCID: PMC1850749          DOI: 10.1016/S0002-9440(10)64197-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies.

Authors:  T G Willis; M J Dyer
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

2.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Authors:  Margaret A Shipp; Ken N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo C T Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill Mesirov; Donna S Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

3.  Fluorescence in situ hybridization of YAC clones after Alu-PCR amplification.

Authors:  C Lengauer; E D Green; T Cremer
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

4.  Simultaneous detection of MYC, BVR1, and PVT1 translocations in lymphoid malignancies by fluorescence in situ hybridization.

Authors:  K A Rack; E Delabesse; I Radford-Weiss; P Bourquelot; G Le Guyader; M Vekemans; E A Macintyre
Journal:  Genes Chromosomes Cancer       Date:  1998-11       Impact factor: 5.006

Review 5.  Molecular features of B-cell lymphoma.

Authors:  R Siebert; A Rosenwald; L M Staudt; S W Morris
Journal:  Curr Opin Oncol       Date:  2001-09       Impact factor: 3.645

6.  Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics.

Authors:  K Weber-Matthiesen; J Deerberg-Wittram; A Rosenwald; M Poetsch; W Grote; B Schlegelberger
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

7.  Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas.

Authors:  R Siebert; P Matthiesen; S Harder; Y Zhang; A Borowski; R Zühlke-Jenisch; S Metzke; S Joos; K Weber-Matthiesen; W Grote; B Schlegelberger
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

8.  Identification of MYCN Copy Number Heterogeneity by Direct FISH Analysis of Neuroblastoma Preparations.

Authors: 
Journal:  Mol Diagn       Date:  1996-12

9.  The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma.

Authors:  I Wlodarska; C De Wolf-Peeters; B Falini; G Verhoef; S W Morris; A Hagemeijer; H Van den Berghe
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

10.  Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.

Authors:  A Rosenwald; A A Alizadeh; G Widhopf; R Simon; R E Davis; X Yu; L Yang; O K Pickeral; L Z Rassenti; J Powell; D Botstein; J C Byrd; M R Grever; B D Cheson; N Chiorazzi; W H Wilson; T J Kipps; P O Brown; L M Staudt
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

View more
  13 in total

1.  Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition.

Authors:  Christoph Renné; José Ignacio Martín-Subero; Martin-Leo Hansmann; Reiner Siebert
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

2.  Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events.

Authors:  Iwona Wlodarska; Christine Matthews; Ellen Veyt; Helena Pospisilova; Mark A Catherwood; Tim S Poulsen; Vera Vanhentenrijk; Rachel Ibbotson; Peter Vandenberghe; T C M Curly Morris; H Denis Alexander
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

3.  Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections.

Authors:  Victoria Bedell; Stephen J Forman; Karl Gaal; Vinod Pullarkat; Lawrence M Weiss; Marilyn L Slovak
Journal:  J Mol Diagn       Date:  2007-11       Impact factor: 5.568

4.  Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component.

Authors:  Carlo Visco; Sylvia Hoeller; Jeffrey T Malik; Zijun Y Xu-Monette; Michele L Wiggins; Jessica Liu; Warren G Sanger; Zhongfeng Liu; Julie Chang; Erik A Ranheim; Joel F Gradowski; Sergio Serrano; Huan-You Wang; Qingquan Liu; Sandeep Dave; Brian Olsen; Randy D Gascoyne; Elias Campo; Steven H Swerdlow; Wing C Chan; Alexander Tzankov; Ken H Young
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

5.  Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.

Authors:  James R Cook; Marybeth Hartke; James Pettay; Raymond R Tubbs
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

Review 6.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

Authors:  Roland A Ventura; Jose I Martin-Subero; Margaret Jones; Joanna McParland; Stefan Gesk; David Y Mason; Reiner Siebert
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

7.  Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer.

Authors:  Birgitta Schlüter; Roswitha Gerhards; Dirk Strumberg; Rudolf Voigtmann
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

8.  Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.

Authors:  Kai Fu; Dennis D Weisenburger; Timothy C Greiner; Sandeep Dave; George Wright; Andreas Rosenwald; Michael Chiorazzi; Javeed Iqbal; Stefan Gesk; Reiner Siebert; Daphne De Jong; Elaine S Jaffe; Wyndham H Wilson; Jan Delabie; German Ott; Bhavana J Dave; Warren G Sanger; Lynette M Smith; Lisa Rimsza; Rita M Braziel; H Konrad Müller-Hermelink; Elias Campo; Randy D Gascoyne; Louis M Staudt; Wing C Chan
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

9.  Image cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspension.

Authors:  Hans Minderman; Kristen Humphrey; Jane K Arcadi; Andrzej Wierzbicki; Orla Maguire; Eunice S Wang; AnneMarie W Block; Sheila N J Sait; Thaddeus C George; Paul K Wallace
Journal:  Cytometry A       Date:  2012-07-26       Impact factor: 4.355

10.  TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.

Authors:  Roland Schmitz; Martin-Leo Hansmann; Verena Bohle; Jose Ignacio Martin-Subero; Sylvia Hartmann; Gunhild Mechtersheimer; Wolfram Klapper; Inga Vater; Maciej Giefing; Stefan Gesk; Jens Stanelle; Reiner Siebert; Ralf Küppers
Journal:  J Exp Med       Date:  2009-04-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.